Pura Vida Investments’s Opus Genetics IRD Stock Holding History

Pura Vida Investments’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-57,536	Closed	-$334K	–	280
2021 Q1	$334K	Buy	+57,536	New	+$535K	0.01%	209

Other funds holding IRD

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

NPF

Norris Perne & French Grand Rapids, Michigan $1.71B AUM 30.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pura Vida Investments's IRD Position: Q2 2021 in Review

Pura Vida Investments sold out of Opus Genetics (IRD) in Q2 2021, closing a stake of 57,536 shares — an estimated $334K sold.

Pura Vida Investments first reported a position in IRD in Q1 2021 and held it in 1 quarter. The position peaked at $334K in Q1 2021. 36 funds tracked by Wall St. Rank hold IRD as of Q2 2021.

Pura Vida Investments reported no remaining Opus Genetics position as of Q2 2021 after selling out during the quarter.
Pura Vida Investments sold 57,536 Opus Genetics shares in Q2 2021, an estimated $334K.
Pura Vida Investments first reported a position in Opus Genetics in Q1 2021 and held it in 1 quarter.
Pura Vida Investments's Opus Genetics position peaked at $334K in Q1 2021.
36 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.